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1.1. Caspase-3 inhibitors
The molecular mechanisms of apoptosis are becoming
clearer with study, and the importance of a group of cy-
steinyl aspartate speciﬁc proteases (caspases) has be-
come apparent in the programmed cell death process.
To date, 13 human caspases have been identiﬁed and
these enzymes exist as dormant proenzymes which are
processed to the catalytically active mature forms under
certain conditions.
Caspases are grouped into three subfamilies based upon
their substrate speciﬁcity and cellular functions. Group I
(1, 4 and 5) caspases are believed to be involved primarily
in inﬂammation, whilst Group II (2, 3, 6 and 7) and
Group III (6, 8, 9 and 10) caspases are essential for apop-
totic cell death. Caspase-3 (casp-3) has been character-
ised as the dominant eﬀector caspase involved in the
proteolytic cleavage of a variety of protein substrates,
including cytoskeletal proteins, kinases and DNA repair
enzymes, during apoptosis. A casp-3 knockout murine
phenotype suggested the necessity of this enzyme during
brain development and recent studies revealed its activa-
tion in many models of apoptosis. Thus the development
of potent and selective casp-3 inhibitors has emerged as
an attractive therapeutic target.
Recent reports have also indicated that caspase inhibi-
tors were eﬀective in animal models of ischemia injury,
burns, endotoximia and neonatal hypoxia. These inhib-
itors, however, are either irreversible pan-caspase inhib-
itors, inhibit other cysteine proteases, or have poor
whole cell activity and in vivo stability. In order to assess
the importance of casp-3 activation in apoptosis, potent
selective and reversible inhibitors are needed. Recently
such inhibitors have been discovered.1doi:10.1016/j.comche.2004.07.001
E-mail: nick_terrett@cambridge.pﬁzer.comA library of 100 compounds was synthesised employ-
ing a split and pool protocol using the IRORI Macro-
Kan technology. Four of the most potent compounds
identiﬁed at this stage were re-synthesised and assayed
against casp-1, 3, 7 and 8. All of these inhibitors were
found to be selective, fully reversible and competitive
against rh-casp-3. One compound (i) was active in an
NT2 whole cell assay with an IC50 of 10 lM. Here,
the potency of compounds to inhibit camptothecin-
induced apoptotic cell death in the neuronal precursor
(NT2) cells was determined. Compound (i) was then
the starting point for a further two rounds of optimisa-
tion with a further 600 compounds synthesised. This led
to the discovery of (ii) which was even more potent (IC50
53 nM) It was shown that compound (ii), because it
contains an ester group, is acting as a prodrug, leading
to enhanced whole cell activity because of improved cell
permeability. Further medicinal chemistry design led to
(iii) with excellent intrinsic and whole cell potency with
IC50 values of 5 nM and 1000 nM respectively, and
selectivity against other caspases tested. This work is
of interest as it provides valuable tools for studying
the importance of casp-3 activation in cell based
systems.1.2. Antiplasmodial activity
Malaria is the most common parasitic disease in the
world, each year aﬀecting more than 6% of the global
population, primarily in regions between the tropics of
Cancer and Capricorn. Although most people who be-
come ill survive after an illness lasting 10–20 days, ma-
laria kills between 1 and 2 million people annually,
thus making it one of the major causes of mortality in
developing countries.
Many diﬀerent drugs have been used to prevent and
treat malaria. The best known, safest and one of the
most eﬀective antimalarials is chloroquine, a drug used
for both treatment and chemoprophylaxis. However,
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developed. Recent work has undertaken the study of a
series of novel bisbenzamidines which diﬀer from previ-
ously described analogues as the aromatic moieties are
linked by a conformationally restricted structure.2
A small library of 11 analogues was prepared in solution
as singletons, and the antiplasmodial activities of the
compounds determined by their ability to inhibit the
incorporation of 3H-hypoxanthine into nucleic acid via
the parasite purine salvage pathway. Each compound
from this library was evaluated for activity against two
Plasmodium falciparum strains: a cloned chloroquine-
susceptible strain from Haiti (Haiti 135) and a cloned
chloroquine-resistant strain from Indochina (Indochina
I). Results were reported as the concentrations of the
test compounds necessary to inhibit the incorporation
of 3H- hypoxanthine by 50% (IC50).
One of the most potent compounds discovered from this
work was (iv) with an IC50 of 3 nM against the strain
Haiti 135, and an IC50 of 4 nM against Indochina I.
Aromatic diamines are prescribed widely for the treat-
ment of fungal and protozal infections, despite their side
eﬀects. However, diamidines have not been evaluated
extensively as potential antimalarials. The results of this
work indicate that piperazine-linked bisbenzamidines
are highly active against both chloroquine-susceptible
and chloroquine-resistant Plasmodium falciparum. Com-NH
NH2
N N
NH2
NH
(iv)
.HClClH.pound (iv) is 50-fold more active than chloroquine itself
against the chloroquine-resistant Indochina I strain of
Plasmodium falciparum. Thus the 4,4 0-(piperazine-1,4-
diyl)bisbenzamidines are a promising novel class of
compounds with potential antimalarial activity.2. A summary of the papers in this months issue
2.1. Solid-phase synthesis
Polymer-supported N-benzyl- and N-benzhydryl-2-
nitrobenzenesulfonamides have been N-alkylated using
three diﬀerent routes: via Fukuyama reaction with
alcohols, by N-alkylation with electrophiles, and by
Michael addition reaction with, a,b-unsaturated carbo-
nyl compounds. N-alkylation of polymer-supported
2-nitrobenzenesulfonamide linkers represents an alter-
native route to reductive amination of aldehyde linkers.3
The N-alkylation of polymer-supported N-benzyloxy-2-
nitrobenzenesulfonamides was undertaken using three
diﬀerent routes: via Fukuyama reaction with alcohols,
by N-alkylation with alkylbromides, and by Michael
addition reaction with, a,b-unsaturated carbonyl com-
pounds. The 2-nitrobenzenesulfonyl (Nos) group was
cleaved under mild conditions to yield polymer-sup-
ported N-alkylated benzyloxyamines. Acylation by
carboxylic acids and cleavage with TFA yielded N-alkyl
hydroxamic acids.42.2. Solution-phase synthesis
In a method that lends itself to parallel synthesis, func-
tionalized quinoxalines and heterocyclic pyrazines have
been expediently prepared in excellent yields (69–99%)
from common 1,2-diketone intermediates under micro-
wave irradiation.5
Collections of small secondary amines for compound
library generation can be eﬃciently prepared by amide
reduction using BH3–THF or Red-Al followed by brief
methanolysis, trapping with di-tert-butyl dicarbonate,
and deprotection with 4M HCl in dioxane.62.3. Scaﬀolds for combinatorial libraries
It has been reported that disulﬁde-linked dynamic glyco-
peptide libraries can be constructed from 1-thiosugar
and cysteine-rich oligopeptide building blocks upon gen-
tle air oxidation of a slightly basic (pH 7.8) aqueous
solution. A mixture of 1-thiogalactose and two oligo-
peptides H2N–CysGlyCysGly–CO2H and H2N–Gly-
CycCysGlyGly–CO2H, for example, aﬀords a poorly
HPLC-resolved disulﬁde library composed of various
sugar–peptide conjugates and cyclic peptides.7
Peptide nucleic acids (PNAs), C- or N-modiﬁed with
dioxime ligands have been prepared by solid-phase
synthesis using iron(II)-clathrochelates as protected
dioxime building blocks.8
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dimethyl-3-amidotetrahydrofuran-4-one, its (2S,3R)-
epimer and (3aR,6aR)-N-(3-oxo-hexahydrocyclopenta-
[b]furan-3a-yl)acylamide cysteinyl proteinase inhibitors
has been developed using Fmoc-protected scaﬀolds in a
solid-phase combinatorial strategy. These have been used
in a solid-phase synthesis of peptidomimetic inhibitors of
a range of CAC1 cysteinyl proteinases.9
2.4. Solid-phase supported reagents
A series of dialkyl-[2-(3-alkylsulfanylmethyl-1H-indol-2-
yl)-ethyl]amines has been produced using a novel route
involving nucleophilic ring opening of 2,2-dialkyl-
1,2,3,4-tetrahydro-c-carbolinium salts with thiols. The
insertion reaction was mediated by a strong, polymer-
supported base, and the puriﬁcation of the target
compounds was facilitated using resin-bound sulfonic
acid.10
Cross-linked polymer-bound lithium dialkylamides have
been employed in crossed aldol reaction of various
carbonyl compounds with aldehydes to aﬀord the cor-
responding b-hydroxycarbonyl compounds. The intro-
duction of spacer chains to the polymer-bound lithium
dialkylamide between the base moiety and the polysty-
rene backbone eﬀectively enhanced yields of the desired
aldol adducts.112.5. Novel resins, linkers and techniques
A method for the chemoselective introduction of spacer
modiﬁed biotin labels into unprotected multi-functional
amines has been developed. A range of novel biotin
spacer conjugates attached to a polymer-bound sulfon-
amide anchor have been prepared using established
amide bond forming procedures.122.6. Library applications
Incorporation of an SRI (serotonin reuptake inhibitor)
pharmacophore into a selective 5-HT1D agonist has led
to the discovery of a molecule having both 5-HT1D
antagonist and SRI activity. Parallel synthesis method-
ology was used to develop the SAR and identify poten-
tial approaches to reduce unwanted adrenergic a1 and
dopamine D2 cross-reactivities.
13
A series of novel, highly potent, achiral factor Xa inhib-
itors based on a benzoic acid scaﬀold and containing a
chlorophenethyl moiety directed towards the protease
S1 pocket has been described.14
A small library of kojic acid-tripeptides (Ko-X1X2X3)
has been prepared by solid-phase parallel synthesis
and assayed to evaluate their tyrosinase inhibitory activ-
ity. Most of the kojic acid-tripeptides showed better
activities than kojic acid.15
A series of purine based inhibitors of PDE7 has been
derived from a screening lead, and the solid-phase syn-
thesis, structure-activity relationships (SAR), and selec-tivity against several other PDE family members have
been described.16
The design and parallel synthesis of potent, small mole-
cule partial agonists of Neuromedin B receptor based
on the 3-amino-2,3,4,9-tetrahydro-1H-carbazole-3-carb-
oxylic acid amide core has been described.17
Using a newly developed multicomponent chemistry
strategy in combination with structure based drug de-
sign, a new class of HIV-1 protease inhibitors has been
obtained.18
A noncovalent carbohydrate microarray has been used
to screen for possible inhibitors to fucosyltransferases,
which are critical to the synthesis of inﬂammation medi-
ators like sialyl Lewis x (SLex).19
A recent paper describes the synthesis, using parallel
solution-phase methods, of a library of 104 potential
inhibitors of protein tyrosine phosphatases (PTPases).
The library members are based on the bis(aryl-ketocarb-
oxylic acid) motif that incorporates a carboxylic acid on
the central benzene linker.20References
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